Delivery Order SPE2DB20D1109-SPE2DB24FN60B

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $30K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $17,433.36, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical treatments. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,710.52 with a firm fixed price and a completion date of February 13, 2024. The contract is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, to support DLA Troop Support Medical and other federal medical facilities. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,651.87 firm fixed-price delivery order is for the provision of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various medical applications. The contract has an ultimate completion date of March 11, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The single-award, Firm Fixed Price Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $16,319.54. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a performance period ending on March 24, 2022. The award was made on March 23, 2022, and there was no set-aside designation...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product used for various healthcare needs. The contract has a ceiling value of $8,674.70 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,219.79 contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products to be completed by February 12, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the sole...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,727.55, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, and has an ultimate completion date of February 27, 2025. The contract is a Delivery Order under a Firm Fixed Price type. This award is not designated with a set-aside and appears to be part of a larger Indefinite...
This federal contract award, valued at $2,864.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,300.52 delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML syringes. The contract has an ultimate completion date of October 24, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN60B
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $29,725.52, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024.

Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is one of the numerous delivery orders placed under this IDC. There is no set-aside designation for this contract.

Generated 5/14/25, 10:13 AM